1. bookVolume 52 (2018): Issue 4 (October 2018)
Journal Details
License
Format
Journal
eISSN
1336-0329
First Published
30 Mar 2016
Publication timeframe
4 times per year
Languages
English
access type Open Access

Enhanced intestinal 2-deoxy-2-[18F]fluoro-D-glucose uptake under metformin is not fully suppressed by loperamide

Published Online: 22 Nov 2018
Volume & Issue: Volume 52 (2018) - Issue 4 (October 2018)
Page range: 185 - 191
Journal Details
License
Format
Journal
eISSN
1336-0329
First Published
30 Mar 2016
Publication timeframe
4 times per year
Languages
English
Abstract

Objective. This study investigated whether the metformin (Met)-induced enhanced intestinal uptake of 2-deoxy-2-[18F]fluoro-D-glucose (18F-FDG) is reduced by loperamide, a long-acting anti-diarrheal agent. Methods. Mean 18F-FDG uptake in the mouse small intestine and colon with Met exposure was compared with that in control mice. In the Met group, high-dose (1.0 mg/kg body weight) and low-dose (0.1 mg/kg body weight) loperamide were introduced, and 18F-FDG uptake in the small intestine and colon was compared with that of control mice administered high-dose loperamide. The percent injected dose of 18F-FDG per gram of tissue (%ID/g) in the extracted tissues was then determined. Results. 18F-FDG uptake increased significantly in the small intestine (0.64±0.06 vs. 1.01±0.15, p=0.040) and, especially, the colon (0.46±0.13 vs. 2.16±0.51, p<0.001) after Met exposure. Neither high-dose nor low-dose loperamide significantly reduced 18F-FDG uptake in the small intestine (0.82±0.31 vs. 0.84±0.22, p=0.93 and 0.78±0.25 vs. 0.70±0.15, p=0.13, respectively) or colon (2.13±0.41 vs. 1.67±0.55, p=0.063 and 1.77±0.39 vs. 1.80±0.25, p=0.56, respectively). The colonic %ID/g was significantly higher in Met groups irrespective of loperamide introduction than in control group, whereas the significant difference in the small intestine was observed only between Met and control groups. Conclusion. Metformin increased 18F-FDG uptake in intestines especially in colon. Loperamide administration partially, but not sufficiently, suppresses the Met-induced increased colonic uptake of 18F-FDG.

Keywords

Chen W, Chung HH, Cheng JT. Opiate-induced constipation related to activation of small intestine opioid mu2- receptors. World J Gastroenterol 18, 1391-1396, 2012.10.3748/wjg.v18.i12.139122493554Open DOISearch in Google Scholar

Gontier E, Fourme E, Wartski M, Blondet C, Bonardel G, Le Stanc E, Mantzarides M, Foehrenbach H, Pecking AP, Alberini JL. High and typical 18F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging 35, 95-99, 2008.10.1007/s00259-007-0563-6Open DOISearch in Google Scholar

Kojima S, Ikeda M, Kamikawa Y. Loperamide inhibits tachykinin NK3-receptor-triggered serotonin release without affecting NK2-receptor-triggered serotonin release from guinea pig colonic mucosa. J Pharmacol Sci 98, 175-180, 2005.1594212510.1254/jphs.FPJ05011XSearch in Google Scholar

Krevsky B, Cowan A, Maurer AH, Butt W, Fisher RS. Effects of selective opioid agonists on feline colonic transit. Life sci 48, 1597-1602, 1991.185005910.1016/0024-3205(91)90285-JSearch in Google Scholar

Lee SH, Jin S, Lee HS, Ryu JS, Lee JJ. Metformin discontinuation less than 72 h is suboptimal for F-18 FDG PET/CT interpretation of the bowel. Ann Nucl Med 30, 629-636, 2016.2739294710.1007/s12149-016-1106-7Search in Google Scholar

Massollo M, Marini C, Brignone M, Emionite L, Salani B, Riondato M, Capitanio S, Fiz F, Democrito A, Amaro A, Morbelli S, Piana M, Maggi D, Cilli M, Pfeffer U, Sambuceti G. Metformin temporal and localized effects on gut glucose metabolism assessed using 18F-FDG PET in mice. J Nucl Med 54, 259-266, 2013.10.2967/jnumed.112.106666Open DOISearch in Google Scholar

McCreight LJ, Bailey CJ, Pearson ER. Metformin and the gastrointestinal tract. Diabetologia 59, 426-435, 2016.10.1007/s00125-015-3844-9Search in Google Scholar

Oh JR, Song HC, Chong A, Ha JM, Jeong SY, Min JJ, Bom HS. Impact of medication discontinuation on increased intestinal FDG accumulation in diabetic patients treated with metformin. Am J Roentgenol 195, 1404-1410, 2010.10.2214/AJR.10.4663Search in Google Scholar

Ozulker T, Ozulker F, Mert M, Ozpacaci T. Clearance of the high intestinal (18)F-FDG uptake associated with metformin after stopping the drug. Eur J Nucl Med Mol Imaging 37, 1011-1017, 2010.10.1007/s00259-009-1330-7Search in Google Scholar

Schiller LR, Santa Ana CA, Morawski SG, Fordtran JS. Mechanism of the antidiarrheal effect of loperamide. Gastroenterology 86, 1475-1480, 1984.10.1016/S0016-5085(84)80161-4Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo